Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Should US FDA Refuse Approval If Women Under-Represented In Clinical Trials?

Executive Summary

Idea suggested during 'Great Debate,' but agency official says no adlibbing is allowed in the regulations.

You may also be interested in...



Clinical Trial Diversity: FDA Rejects Calls For Enrollment Mandates

Requiring that underrepresented populations be enrolled based upon disease prevalence is only way to ensure adequate diversity, some stakeholders say; agency continues to prefer more flexible approach offered by guidance, and PhRMA says mandates would lengthen development timelines for new drugs.

Clinical Trial Subgroup Data: How Much Is Enough?

FDA could use epidemiology data on disease prevalence or insurance claims data to determine acceptable subgroup sizes, advocates say.

PhRMA’s “I’m In” Campaign Looks To Connect Minorities To Studies

Extension of the Clinical Trial Engagement Network is aimed at increased diversity in clinical trials, which is becoming increasingly important as more drugs are targeted at specific groups.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS123128

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel